The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex complicated synthetic process. Initial routes focused on peptide section coupling, utilizing solid-phase https://nettiexezq520568.blogcudinti.com/40852982/production-and-study-implementations-of-retatrutide